谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Frequency and Characteristics of Infusion Reactions During Biosimilar Infliximab Treatment in Inflammatory Bowel Diseases: Results from Central European Nationwide Cohort

Anita Balint,Mariann Rutka,Zsuzsanna Vegh,Zsuzsanna Kurti,Krisztina B. Gecse,Janos Banai,Laszlo Bene,Beata Gasztonyi,Tunde Kristof,Laszlo Lakatos,Pal Miheller,Karoly Palatka,Arpad Patai,Agnes Salamon,Tamas Szamosi,Zoltan Szepes,Gabor Tamas Toth,Aron Vincze,Renata Bor,Agnes Milassin,Anna Fabian,Ferenc Nagy,Martin Kolar,Martin Bortlik,Dana Duricova,Veronika Hruba,Martin Lukas,Katarina Mitrova,Karin Malickova,Milan Lukas,Peter L. Lakatos,Tamas Molnar,Klaudia Farkas

Expert Opinion on Drug Safety（2017）

引用 26|浏览1
关键词
Crohn's disease,ulcerative colitis,infliximab,biosimilar,CT-P13,infusion reaction
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要